谷歌浏览器插件
订阅小程序
在清言上使用
VIPCreated with Sketch.

Discovery of a First-in-class Reversible DNMT1-selective Inhibitor with Improved Tolerability and Efficacy in Acute Myeloid Leukemia.

Melissa B. Pappalardi,Kathryn Keenan,Mark Cockerill,Wendy A. Kellner,Alexandra Stowell,Christian Sherk,Kristen Wong,Sarath Pathuri,Jacques Briand,Michael Steidel,Philip Chapman,Arthur Groy,Ashley K. Wiseman,Charles F. McHugh,Nino Campobasso,Alan P. Graves,Emma Fairweather,Thilo Werner,Ali Raoof,Roger J. Butlin,Lourdes Rueda,John R. Horton,David T. Fosbenner,Cunyu Zhang,Jessica L. Handler,Morris Muliaditan,Makda Mebrahtu,Jon-Paul Jaworski,Dean E. McNulty,Charlotte Burt,H. Christian Eberl,Amy N. Taylor,Thau Ho, Susan Merrihew,Shawn W. Foley,Anna Rutkowska,Mei Li,Stuart P. Romeril,Kristin Goldberg,Xing Zhang,Christopher S. Kershaw,Marcus Bantscheff,Anthony J. Jurewicz,Elisabeth Minthorn,Paola Grandi,Mehul Patel,Andrew B. Benowitz,Helai P. Mohammad,Aidan G. Gilmartin,Rab K. Prinjha,Donald Ogilvie,Christopher Carpenter,Dirk Heerding,Stephen B. Baylin,Peter A. Jones,Xiaodong Cheng,Bryan W. King,Juan I. Luengo,Allan M. Jordan,Ian Waddell,Ryan G. Kruger,Michael T. McCabe

Nature cancer（2021）

引用 128|浏览54
关键词
Cancer therapy,Drug discovery,Haematological cancer,Life Sciences,general
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要